Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT03266835 Completed - Clinical trials for Chronic Total Occlusion of Arteries of the Extremities

SoundBite™ Crossing System Pivotal Peripheral CTO Crossing Study

PROSPECTOR
Start date: November 16, 2017
Phase: N/A
Study type: Interventional

This study is aimed at demonstrating the efficacy and safety of the SoundBite™ Crossing System-Peripheral. The study is intended to demonstrate that the SoundBite™ Crossing System can facilitate the passage of either devices intended to treat a chronic total occlusion (CTO) or additional crossing devices through an infrainguinal CTO into the true lumen.

NCT ID: NCT03266523 Completed - Clinical trials for All Conditions for Which a CT or MRI Exam Can be Required

Influence of Natural Images on Patients' Anxiety in the Waiting Rooms of Imaging Ward

VERTIM
Start date: October 3, 2017
Phase: N/A
Study type: Observational

VERTIM study aims to evaluate the influence of different environments of imaging waiting rooms on the anxiety felt by patients before MRI or CT scans. For this, four environments (neutral/standard; and nature "green", "sea", and "zen") will be set up in MRI and CT waiting rooms.

NCT ID: NCT03266146 Completed - Clinical trials for Drug-induced Liver Injury,Chronic

36 Weeks Short-Term Optimization Treatment of Glucocorticosteroid in the Patients With Chronic Recurrent DILI

Start date: September 2, 2017
Phase: Phase 1/Phase 2
Study type: Interventional

This study is to observe the efficacy and safety of 36 weeks short-term optimization treatment of glucocorticosteroid in the patients with chronic recurrent drug-induced liver injury (DILI).

NCT ID: NCT03266133 Completed - Clinical trials for Gestational Diabetes Mellitus in Pregnancy

Sleep Intervention to Improve Glycemic Control in Women With Gestational Diabetes

Start date: November 27, 2017
Phase: N/A
Study type: Interventional

This is a pilot randomized controlled trial involving a sleep education intervention in women with gestational diabetes to study whether sleep education during pregnancy leads to improvement in glycemic control in women with gestational diabetes and improvement in sleep duration.

NCT ID: NCT03265886 Completed - Clinical trials for Surgery to the Distal One Third of the Upper Limb

The Influence of Warm Bupivacaine on Supraclavicular Plexus Block Characteristics

Start date: October 1, 2017
Phase: N/A
Study type: Interventional

Despite PH adjustment of local anesthetic solution improves the quality of the block in all respects with special advantage of early onset of sensory and motor block, adequate level of analgesia, and prolongation of duration of block, the effect of warmed bupivacaine should have the same effect which have not been evaluated on supraclavicular plexus block for upper limb surgery. The warmed bupivacaine used in supraclavicular plexus block may reduce sensory and motor block onset and prolong the duration of analgesia when compared to bupivacaine at operating room temperature.

NCT ID: NCT03265834 Completed - Clinical trials for Complicated Intraabdominal Infections

CABI: Antibiotic Duration for Complicated Intra-ABdominal Infection

CABI
Start date: August 1, 2017
Phase: Phase 2
Study type: Interventional

Complicated intra-ABdominal Infections (CABIs) are abdominal infections where there is an abscess inside the abdomen, or a hole (perforation) in an abdominal organ such that infected material e.g. faeces, leaks into the abdominal cavity. A recent review of CABIs after gut surgery found that they can occur in several ways. They can occur in different parts of the abdomen, can be different sizes, and may or may not be caused by a perforated bowel. Management includes, where possible, surgical drainage of an abscess or treatment of the damaged bowel. In addition, all patients are given antibiotic therapy. Despite the varied ways that CABIs occur, we currently tend to treat all CABIs with antibiotics in a similar way. CABIs are associated with significant morbidity and mortality. Despite a significant amount of disease there is little clinical evidence with which to base treatment on. One research study evaluated a short course of antibiotics (4 days) compared with a longer course (up to 10 days) in combination with surgical removal of infection. There was little difference in outcomes, but in both groups about 1 out of every 7 patients had a relapse. A recent review of patients with CABI in Leeds, not in a research study and where surgical removal infection is uncommon and antibiotic durations were short, showed that the risk of relapse was even higher (about 1 in every 3 patients). The antibiotic management of CABIs in the UK is variable and involves giving between 4 days to 28 days of antibiotics. In summary, there is an unacceptably high relapse rate in patients treated for CABI, and uncertainty about the best length of antibiotic therapy that should be used to prevent these relapses. We therefore propose to investigate if long course antibiotic therapy (28 days) is more effective than short course antibiotics (≤10 days) in preventing relapses of CABI.

NCT ID: NCT03265561 Completed - Syndrome Clinical Trials

Spinal Infection Management With Structural Allograft

Start date: May 14, 2015
Phase: N/A
Study type: Interventional

Background. Bone infections can involve the vertebral column, intervertebral disc space, spinal canal and soft tissues, can generate neurological deficit in addition to the destruction of the bone that causes functional disability. Vertebral osteomyelitis is the most frequent, affecting 2 to 7 patients per 100,000 habitants. Management is bone debridement and bone reconstruction. Objective. Demonstrate that the use of bone allograft is a functional method to stabilize the spine after a bone spinal infection Material and methods. Patients with vertebral bone destruction are included in two groups. Bone allograft group will receive bone structural allograft; Auto and allograft group will receive bone structural allograft plus autograft. The bone reconstruction will be performed in a one-time surgical procedure. Bone consolidation, pain, functionality, and spine deformity will be evaluated.

NCT ID: NCT03265366 Completed - Clinical trials for Allergic Bronchopulmonary Aspergilloses

Diagnostic Value of MRI for Allergic Broncho-Pulmonary Aspergilloses

ABPA-MR
Start date: September 14, 2017
Phase: N/A
Study type: Interventional

The aim of the study is to compare the concordance between chest computerized tomography-scan (CTscan) and Magnetic resonance Imaging (MRI) for the description of the abnormalities seen in Allergic BronchoPulmonary Aspergillosis (ABPA).

NCT ID: NCT03265145 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE]

Start date: September 20, 2017
Phase: Phase 4
Study type: Interventional

The primary objective of this pragmatic study is to compare the time to first moderate or severe COPD exacerbation in patients, not controlled on their current therapy, randomized to Stiolto Respimat versus triple therapy over 12 months of treatment The secondary objectives of this study include: 1. To compare the annual rate of moderate or severe COPD exacerbations for patients on Stiolto Respimat with patients on triple therapy. 2. To compare the time to first severe COPD exacerbation in both treatment arms. 3. To compare the annual rate of severe COPD exacerbations in both treatment arms. 4. To compare the proportion of patients with moderate or severe COPD exacerbations in both treatment arms.

NCT ID: NCT03265119 Completed - Clinical trials for Attention Deficit Hyperactivity Disorder

PART A: Efficacy and Safety of AEVI-001 in Children and Adolescents With ADHD and With mGluR Mutations

Start date: August 28, 2017
Phase: Phase 2
Study type: Interventional

This is PART A of a 2-part, 6-week, double-blind, dose-optimization, parallel-group study in children and adolescents (ages 6-17 years) with ADHD with and without CNVs in specific genes implicated in glutamatergic signaling and neuronal activity. Parts A will include subjects determined to have a specific gene mutations implicated in glutamatergic signaling and neuronal connectivity.